Anzeige
Mehr »
Mittwoch, 10.06.2026 - Börsentäglich über 12.000 News
Vier Bohrlöcher, vier Treffer - bestätigt sich hier ein neues Uran-System?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
21.05.Niowave Breaks Ground on Michigan Production Facility
21.05.United Immunity Acquires Macrophage Assets from Carisma Therapeutics
21.05.Gilead Sciences Completes Acquisition of Tubulis
21.05.Gilead Renews WHO Partnership to Fight Deadly Kala-Azar
21.05.Sartorius Opens New Competence Center in Freiburg, Germany
20.05.Scinai Biopharma Services Names Eilon Elmalem Head of Yavne CDMO Site
20.05.Pinnaql Acquires Pharma Resource Group, Expanding Core Service Area Depth
20.05.Amgen CFO Transition as Peter Griffith Retires, Thomas Dittrich Returns
20.05.Samsung Bioepis Launches Ustekinumab Biosimilar in Japan
20.05.Oxford Nanopore and Lonza Launch mRNA QC Solution for GMP Testing
20.05.Curia Upgrades Aseptic Suites in Valladolid, Spain
20.05.BMS to Deploy Claude Agentic AI Across 30,000 Employees
20.05.Fujifilm Cellular Dynamics Opens New Headquarters & iPSC Manufacturing Facility in Madison
19.05.Passkey Therapeutics Taps Mandeep Kaur as Chief Medical Officer
19.05.Cosette Pharmaceuticals Names David Bell CCO of Brands
19.05.Incyte to Deploy Edison Scientific's AI Scientist Kosmos for R&D
19.05.ATB Therapeutics Names Mark Throsby as CEO
19.05.Vistagen Taps Dr. Angel Angelov as Chief Medical Officer
19.05.Hansa Biopharma Signs IDEFIRIX Licensing Deal With SERB
19.05.Helio Genomics Partners with Syneos Health to Drive Awareness & Adoption of HelioLiver
18.05.AstraZeneca Hypertension Treatment Baxfendy Approved by FDA
18.05.Orca Bio Taps Bijan Nejadnik as New Chief Medical Officer
18.05.Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9B
18.05.AstraZeneca, Daiichi Sankyo's Enhertu Gets New US Approval for Two HER2-Positive Breast Cancer Indications
18.05.ProtaGene Teams With MilliporeSigma on End-to-End Testing